Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis
نویسندگان
چکیده
منابع مشابه
the investigation of the relationship between type a and type b personalities and quality of translation
چکیده ندارد.
Targeted UV-B phototherapy for plaque-type psoriasis.
OBJECTIVE To determine whether targeted UV-B phototherapy is efficacious and safe in the treatment of localized psoriasis and whether there is a dose-response relationship. DESIGN Randomized, evaluator-blind, controlled study. SETTING Dermatology clinic in a large university-based hospital in Bangkok, Thailand. PATIENTS Fourteen patients with stable, localized, plaque-type psoriasis. IN...
متن کاملNarrowband UV-B phototherapy vs photochemotherapy in the treatment of chronic plaque-type psoriasis: a paired comparison study.
OBJECTIVE To compare the therapeutic efficacy of narrowband (TL-01) UV-B phototherapy vs photochemotherapy (psoralen-UV-A [PUVA]) in patients with chronic plaque-type psoriasis. DESIGN Open, nonrandomized, intraindividually controlled paired comparison study. SETTING Phototherapeutic unit in a university hospital. PATIENTS Twenty-five patients with chronic plaque-type psoriasis. INTERVE...
متن کاملA randomized, observer-blinded trial of twice vs. three times weekly narrowband ultraviolet B phototherapy for chronic plaque psoriasis.
BACKGROUND The optimum treatment frequency for narrowband (TL-01) ultraviolet B (NB-UVB) in psoriasis is not yet known. We have previously found three times weekly to be preferable to five times weekly treatment in our population. OBJECTIVES To compare twice weekly with three times weekly NB-UVB phototherapy in chronic plaque psoriasis. METHODS In an observer-blinded, randomized comparison,...
متن کاملEtanercept in the treatment of plaque psoriasis
Etanercept is approved for the treatment of moderate to severe plaque psoriasis at a dose of 50 mg twice weekly for 3 months followed by a maintenance dosage of 50 mg weekly thereafter. Clinical studies have shown excellent efficacy, favorable benefit to side-effects ratio, and safe long-term usage. Extensive information on safety is available as etanercept has been used for many years for othe...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Dermatology
سال: 2013
ISSN: 0007-0963
DOI: 10.1111/bjd.12277